Jänne PA - Search Results

1

A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer.

Wakelee HA, Gettinger S, Engelman J, Jänne PA, West H, Subramaniam DS, Leach J, Wax M, Yaron Y, Miles DR, Lara PN Jr. Wakelee HA, et al. Among authors: janne pa. Cancer Chemother Pharmacol. 2017 May;79(5):923-932. doi: 10.1007/s00280-017-3283-z. Epub 2017 Mar 28. Cancer Chemother Pharmacol. 2017. PMID: 28352985 Free PMC article. Clinical Trial.

2

Chemotherapy for a patient with advanced non-small-cell lung cancer during pregnancy: a case report and a review of chemotherapy treatment during pregnancy.

Jänne PA, Rodriguez-Thompson D, Metcalf DR, Swanson SJ, Greisman HA, Wilkins-Haug L, Johnson BE. Jänne PA, et al. Oncology. 2001;61(3):175-83. doi: 10.1159/000055371. Oncology. 2001. PMID: 11574771 Review.

3

Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America.

Jänne PA, Freidlin B, Saxman S, Johnson DH, Livingston RB, Shepherd FA, Johnson BE. Jänne PA, et al. Cancer. 2002 Oct 1;95(7):1528-38. doi: 10.1002/cncr.10841. Cancer. 2002. PMID: 12237922 Free article.

4

Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: a Phase I study.

Wirth LJ, Lucca J, Ostler P, Fidias P, Lynch C, Jänne PA, Herbst RS, Johnson BE, Sugarbaker DJ, Mathisen DJ, Lukanich JM, Choi NC, Berman SM, Skarin AT. Wirth LJ, et al. Among authors: janne pa. Clin Cancer Res. 2003 May;9(5):1698-704. Clin Cancer Res. 2003. PMID: 12738723 Clinical Trial.

5

Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, "Iressa") on an expanded access study.

Jänne PA, Gurubhagavatula S, Yeap BY, Lucca J, Ostler P, Skarin AT, Fidias P, Lynch TJ, Johnson BE. Jänne PA, et al. Lung Cancer. 2004 May;44(2):221-30. doi: 10.1016/j.lungcan.2003.12.014. Lung Cancer. 2004. PMID: 15084387 Clinical Trial.

6

Basic treatment considerations using chemotherapy for patients with small cell lung cancer.

Johnson BE, Jänne PA. Johnson BE, et al. Among authors: janne pa. Hematol Oncol Clin North Am. 2004 Apr;18(2):309-22. doi: 10.1016/j.hoc.2003.12.008. Hematol Oncol Clin North Am. 2004. PMID: 15094173 Review. No abstract available.

7

Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255.

Tracy S, Mukohara T, Hansen M, Meyerson M, Johnson BE, Jänne PA. Tracy S, et al. Among authors: janne pa. Cancer Res. 2004 Oct 15;64(20):7241-4. doi: 10.1158/0008-5472.CAN-04-1905. Cancer Res. 2004. PMID: 15492241

8

ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines.

Engelman JA, Jänne PA, Mermel C, Pearlberg J, Mukohara T, Fleet C, Cichowski K, Johnson BE, Cantley LC. Engelman JA, et al. Among authors: janne pa. Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3788-93. doi: 10.1073/pnas.0409773102. Epub 2005 Feb 24. Proc Natl Acad Sci U S A. 2005. PMID: 15731348 Free PMC article.

9

[Gefitinib therapy in non-small-cell lung cancer].

Jänne PA. Jänne PA. Duodecim. 2005;121(3):249-51. Duodecim. 2005. PMID: 15787283 Finnish. No abstract available.

10

Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology.

Jänne PA, Engelman JA, Johnson BE. Jänne PA, et al. J Clin Oncol. 2005 May 10;23(14):3227-34. doi: 10.1200/JCO.2005.09.985. J Clin Oncol. 2005. PMID: 15886310 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

490 results

Search Page

Filters